封面
市场调查报告书
商品编码
1672103

全球近距离放射治疗市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Brachytherapy Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: | 出版商: Value Market Research | 英文 107 Pages | 商品交期: 最快1-2个工作天内

价格

全球近距离放射治疗市场规模预计将从 2024 年的 10.9 亿美元增长到 2033 年的 21.2 亿美元,在 2026 年至 2033 年的预测期内呈现 7.72% 的强劲年复合成长率(CAGR)。

受癌症发病率不断上升和针对性治疗方案需求的推动,近距离放射治疗市场正在经历显着增长。近距离放射治疗是一种将放射源直接放置在肿瘤内或附近的放射治疗形式,与传统的外部放射治疗相比,它具有多种优势,包括减少对周围健康组织的暴露并提高治疗精度。随着医疗保健提供者寻求提高患者的治疗效果并最大限度地减少副作用,近距离放射治疗的采用预计会增加,从而使该市场实现强劲扩张。越来越多的临床证据支持近距离放射治疗对治疗前列腺癌、乳癌和子宫颈癌等各种癌症的疗效,这进一步推动了这一趋势。

此外,近距离放射治疗技术的进步正在推动市场创新。新的放射性同位素、改进的输送系统和先进的成像技术的发展正在提高近距离放射治疗程序的有效性和安全性。这些创新不仅改善了治疗结果,而且有助于医疗保健提供者的工作流程更加简化。随着研究不断探索近距离放射治疗的新应用,例如与免疫疗法和其他治疗方式相结合,在改善患者护理和治疗结果的推动下,市场可能会进一步扩大。

此外,对个人化医疗的日益重视正在塑造近距离放射治疗的格局。随着医疗保健提供者越来越多地寻求为个别患者量身定制治疗方案,对灵活且适应性强的近距离放射治疗解决方案的需求可能会增加。这一趋势在晚期癌症治疗中尤其重要,了解肿瘤的具体特征可以显着影响治疗决策。随着近距离放射治疗市场不断发展,技术进步、个人化治疗方法和改善患者治疗效果的关注的融合将在推动其未来成长方面发挥关键作用。

我们的报告经过精心製作,为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分,以确保彻底了解市场格局:

市场概览:市场的详细介绍,包括定义、分类和行业现状概述。

市场动态:深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析:根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局:对主要市场参与者的全面评估,包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测:根据历史资料和当前市场状况,预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析:评估不同地理区域的市场表现,确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会:识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章:前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:近距离放射治疗产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按剂量类型进行的市场吸引力分析
    • 按产品进行市场吸引力分析
    • 市场吸引力分析:按应用
    • 市场吸引力分析:按地区

第四章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球近距离放射治疗市场分析:按剂量类型

  • 按剂量类型概述
  • 按剂量类型进行的历史和预测数据分析
  • 高剂量率 (HDR) 近距离放射治疗
  • 低剂量率 (LDR) 近距离放射治疗

第 6 章:全球近距离放射治疗市场分析:依产品

  • 产品概览
  • 按产品进行的历史和预测数据分析
  • 种子
  • 涂抹器和后装器
  • 电子近距离放射治疗

第 7 章:全球近距离放射治疗市场分析:按应用

  • 概述:按应用
  • 历史和预测数据分析:按应用
  • 摄护腺癌
  • 妇科癌症
  • 乳癌
  • 其他的

第 8 章:全球近距离放射治疗市场分析:按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 9 章:近距离放射治疗公司的竞争格局

  • 近距离放射治疗市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第十章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Varian Medical Systems Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Becton
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Dickinson & Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Elekta AB
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Isoray Medical Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Eckert & Ziegler BEBIG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ICAD Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • CIVCO Medical Solutions
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Theragenics Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中,财务细节和最新发展取决于可用性,对于私人公司,可能不予涵盖

Product Code: VMR11211002

Global Brachytherapy Market size is anticipated to grow from USD 1.09 Billion in 2024 to USD 2.12 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.72% during the forecast period of 2026 to 2033.

The brachytherapy market is experiencing significant growth, driven by the increasing prevalence of cancer and the demand for targeted treatment options. Brachytherapy, a form of radiation therapy that involves placing radioactive sources directly within or near a tumor, offers several advantages over traditional external beam radiation therapy, including reduced exposure to surrounding healthy tissues and improved treatment precision. As healthcare providers seek to enhance patient outcomes and minimize side effects, the adoption of brachytherapy is expected to rise, positioning this market for robust expansion. The growing body of clinical evidence supporting the efficacy of brachytherapy in treating various cancers, including prostate, breast, and cervical cancers, is further fueling this trend.

Moreover, advancements in brachytherapy technologies are driving innovation within the market. The development of new radioactive isotopes, improved delivery systems, and advanced imaging techniques is enhancing the effectiveness and safety of brachytherapy procedures. These innovations not only improve treatment outcomes but also contribute to a more streamlined workflow for healthcare providers. As research continues to explore new applications for brachytherapy, such as in combination with immunotherapy and other treatment modalities, the market is likely to expand further, driven by the promise of improved patient care and outcomes.

Additionally, the growing emphasis on personalized medicine is shaping the brachytherapy landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable brachytherapy solutions is likely to rise. This trend is particularly relevant in the context of advanced cancer treatments, where understanding the specific characteristics of a tumor can significantly impact treatment decisions. As the brachytherapy market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Dosage Type

  • High-Dose Rate (HDR) Brachytherapy
  • Low-Dose Rate (LDR) Brachytherapy

By Product

  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy

By Application

  • Prostate Cancer
  • Gynaecological Cancer
  • Breast Cancer
  • Others
  • COMPANIES PROFILED
  • Varian Medical Systems Inc.
  • Becton
  • Dickinson & Company
  • Elekta AB
  • Isoray Medical Inc.
  • Eckert & Ziegler BEBIG
  • iCAD Inc.
  • CIVCO Medical Solutions
  • Theragenics Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BRACHYTHERAPY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Dosage Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY DOSAGE TYPE

  • 5.1. Overview By Dosage Type
  • 5.2. Historical and Forecast Data Analysis By Dosage Type
  • 5.3. High-Dose Rate (HDR) Brachytherapy Historic and Forecast Sales By Regions
  • 5.4. Low-Dose Rate (LDR) Brachytherapy Historic and Forecast Sales By Regions

6. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Seeds Historic and Forecast Sales By Regions
  • 6.4. Applicators & Afterloaders Historic and Forecast Sales By Regions
  • 6.5. Electronic Brachytherapy Historic and Forecast Sales By Regions

7. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Prostate Cancer Historic and Forecast Sales By Regions
  • 7.4. Gynaecological Cancer Historic and Forecast Sales By Regions
  • 7.5. Breast Cancer Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BRACHYTHERAPY COMPANIES

  • 9.1. Brachytherapy Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF BRACHYTHERAPY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Varian Medical Systems Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Becton
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Dickinson & Company
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Elekta AB
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Isoray Medical Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Eckert & Ziegler BEBIG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. ICAD Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. CIVCO Medical Solutions
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Theragenics Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Dosage Type (USD MN)
  • High-Dose Rate (HDR) Brachytherapy Market Sales By Geography (USD MN)
  • Low-Dose Rate (LDR) Brachytherapy Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Seeds Market Sales By Geography (USD MN)
  • Applicators & Afterloaders Market Sales By Geography (USD MN)
  • Electronic Brachytherapy Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Gynaecological Cancer Market Sales By Geography (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Brachytherapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Brachytherapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Brachytherapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Dosage Type
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Dosage Type (USD MN)
  • High-Dose Rate (HDR) Brachytherapy Market Sales By Geography (USD MN)
  • Low-Dose Rate (LDR) Brachytherapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Seeds Market Sales By Geography (USD MN)
  • Applicators & Afterloaders Market Sales By Geography (USD MN)
  • Electronic Brachytherapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Gynaecological Cancer Market Sales By Geography (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.